OGOri Goldberg

Ori Goldberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ori Goldberg has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Dario Prais

    Pulmonary Institute, Schneider Children's Medical Center of Israel, and Gray School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel

    2 shared publications
  • Einat Shmueli

    Pulmonary Institute, Schneider Children's Medical Center of Israel, and Gray School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel

    2 shared publications
  • Noga Yaniv

    Research Authority, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel, Petach, Israel

    2 shared publications
  • Patrick Stafler

    Pulmonary Institute, Schneider Children's Medical Center of Israel, and Gray School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel

    2 shared publications
  • Yoav Vardi

    Pulmonary Institute, Schneider Children's Medical Center of Israel, and Gray School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel

    2 shared publications
  • Yoel Levinsky

    Pulmonary Institute, Schneider Children's Medical Center of Israel, and Gray School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel

    2 shared publications

Latest Publications

  • Fever duration and radiographic yield in children with clinically diagnosed community-acquired pneumonia

    by Ori Goldberg, Yoav Vardi, Yoel Levinsky, Einat Shmueli, Noga Yaniv, Ron Berant, Meir Mei-Zahav, Dario Prais, Patrick Stafler

    Background: Chest radiography (CXR) is often used to support suspected community-acquired pneumonia (CAP), though guideline indications vary. An initially negative CXR may be reassuring, but radiographic changes, particularly pleural complications, can develop later. How radiographic yield varies with fever duration and age is poorly defined. Objectives: To determine whether fever duration is associated with radiographic confirmation of pneumonia and pleuropneumonia in children with clinical CAP, stratified by age. Methods: Retrospective review of 523 children (2-18y) presenting to a tertiary emergency department with clinical CAP (respiratory symptoms, fever ≥38°C) and radiologist-read CXR. Fever duration was categorized as 0-1, >1-3, >3-7, and >7 days. Radiographic pneumonia and pleuropneumonia rates were compared across categories using chi-square test for trend, stratified by age. Results: Overall, radiographic pneumonia increased from 62.9% (95% CI 54.0-71.2%) at 0-1d to 81.0% (95% CI 68.6-90.1%) at >7d (p=0.001); pleuropneumonia from 4.0% to 24.1% (p<0.001). In children 2-5y, pneumonia rose from 58.8% to 76.5% (p=0.015) and pleuropneumonia from 1.3% to 23.5% (p5y, early yield was high, increasing from 70.5% to 87.5% (p=0.040); pleuropneumonia increased from 9.1% to 25.0% (p=0.022) (Figure 1). Conclusions: Radiographic confirmation increases with fever duration, most pronounced in children aged 2-5 years; age and fever duration may inform imaging timing decisions in pediatric CAP. erj;68/suppl_70/PA1705/F1 F1 F1

  • Fever Duration Enhances Biomarker Sensitivity for Diagnosing Pediatric community acquired pneumonia

    by Ori Goldberg, Einat Shmueli, Yoel Levinsky, Yoav Vardi, Noga Yaniv, Ophir Bar-On, Hagit Levine, Meir Mei Zahav, Dario Prais, Patrick Stafler

    Objectives: Investigate the influence of fever duration on the diagnostic performance of readily available blood biomarkers for community-acquired pneumonia (CAP) in children. Study Design:We retrospectively analyzed 3346 children (2-18) with physician-diagnosed CAP at a teritary hospital ER, excluding those with major comorbidities or missing data (fever duration, biomarkers, chest X-rays). Optimal biomarker cutoffs were identified. AUC assessed biomarker performance for differentiating radiological definite CAP from LRTI symptoms. Of the 509 children meeting inclusion criteria (363 definite CAP), Neutrophil-Lymphocyte Ratio (NLR)(cutoff 4.5) displayed significant discriminatory power from days 2-5, peaking on day 4 with AUC 0.70 (95% CI: 0.54-0.86). WBC (15,000/mm³) and ANC (11,200/mm³) peaked on day 2, while CRP (6.23 mg/dl) peaked on day 4 with AUC 0.81 (95% CI: 0.67-0.95). None reliably diagnosed CAP on day 1. erj;64/suppl_68/OA1992/F1 F1 F1 Conclusions: This study underscores the time-dependent nature of biomarker performance in pediatric CAP. While no biomarker reliably diagnosed CAP on day 1, NLR demonstrated consistent reliability across multiple days, peaking on day 4. These findings support its potential for clinical decision-making and highlight the importance of considering fever duration for optimal diagnostic accuracy.

  • Open Access

    Overestimation of Oxygen Saturation Measured by Pulse Oximetry in Hypoxemia. Part 1: Effect of Optical Pathlengths-Ratio Increase

    by Eyal Elron, Ruben Bromiker, Ori Gleisner, Ohad Yosef-Hai, Ori Goldberg, Itamar Nitzan, Meir Nitzan

    On average, arterial oxygen saturation measured by pulse oximetry (SpO2) is higher in hypoxemia than the true oxygen saturation measured invasively (SaO2), thereby increasing the risk of occult hypoxemia. In the current article, measurements of SpO2 on 17 cyanotic newborns were performed by means of a Nellcor pulse oximeter (POx), based on light with two wavelengths in the red and infrared regions (660 and 900 nm), and by means of a novel POx, based on two wavelengths in the infrared region (761 and 820 nm). The SpO2 readings from the two POxs showed higher values than the invasive SaO2 readings, and the disparity increased with decreasing SaO2. SpO2 measured using the two infrared wavelengths showed better correlation with SaO2 than SpO2 measured using the red and infrared wavelengths. After appropriate calibration, the standard deviation of the individual SpO2−SaO2 differences for the two-infrared POx was smaller (3.6%) than that for the red and infrared POx (6.5%, p < 0.05). The overestimation of SpO2 readings in hypoxemia was explained by the increase in hypoxemia of the optical pathlengths-ratio between the two wavelengths. The two-infrared POx can reduce the overestimation of SpO2 measurement in hypoxemia and the consequent risk of occult hypoxemia, owing to its smaller increase in pathlengths-ratio in hypoxemia.


  • Open Access

    Lactose-Containing Dry-Powder Inhalers for Patients with Cow’s Milk Protein Allergy—The Conundrum; A National Survey of Pediatric Pulmonologists and Allergologists

    by Ophir Bar-On, Hagit Levine, Patrick Stafler, Einat Shmueli, Eyal Jacobi, Ori Goldberg, Guy Steuer, Dario Prais, Meir Mei-Zahav

    Introduction: Several dry-powder inhalers (DPIs) contain lactose which may be contaminated with milk proteins. Confusion exists pertaining to DPI use in patients with cow’s milk protein allergy (CMPA). Methods: A computerized survey sent via e-mail to pediatric pulmonologists and allergologists. Results: A total of 77 out of 232 (33.2%) doctors replied, of whom 80.5% were pediatric pulmonologists. A total of 69 of 77 (89.6%) were specialists, 37.6% with more than 15 years of experience. The most commonly used DPIs were formoterol + budesonide and vilanterol + fluticasone. A total of 62 out of 77 (80.5%) responders knew these DPIs contained lactose. A total of 35 out of 77 (45.5%) doctors who replied did not know that DPI leaflets list CMPA as a contra-indication to DPI administration. Of these, 4 (11.4%) stated that they would instruct patients with CMPA to stop DPIs, and 7 (20%) would avoid recommending DPIs. A total of 42 out of 77 (54.5%) responders were aware of this warning, yet 13 of these 42 (30.9%) continued to recommend lactose-containing DPIs without hesitation and 18 of these 42 (42.8%) responders prescribed DPIs but considered allergy severity. Conclusions: Almost half of certified, experienced pediatric pulmonologists and allergologists were unaware of the warning to administer DPIs to patients with CMPA. Most doctors who do know of this warning still continue to prescribe these DPIs.